Zacks Investment Research
28 Oct 2026, 20:45 UTC · 2h ago
UHS Misses Q3 Earnings Estimates Despite Higher Patient Volumes
Impact · against what's priced in
UHS faces earnings compression as rising operating costs and price erosion in Acute Care offset revenue growth and volume gains. The missed EPS estimate and decline in bottom line indicate a squeeze on margins that weighs on the stock.
- UHS−0.30
No priced-in read yet
- In context
Adjusted EPS of $5.22 missed estimates by 1.7% and the bottom line fell 8.3% year-over-year, driven by $4.3 billion in operating expenses that exceeded estimates by $100 million.
Read from the article alone
Top 1 mover · tap to explore
